ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Pseudoephedrine → n1-[(1r,2s)-2-Hydroxy-1-methyl-2-phenylethyl]-n1-methyl-2-[4-amino-3-(4-{[(2,3-dichlorophenyl)sulfonyl]amino}-3-fluorophenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl]acetamide

HRID 897662
印刷

反応式

HRID 897662 の反応式
[CH3:1][C@H:2]([NH:11][CH3:12])[C@@H:3]([OH:10])[C:4]1[CH:9]=[CH:8][CH:7]=[CH:6][CH:5]=1.C([Li])CCC.[NH2:18][C:19]1[N:24]=[CH:23][N:22]=[C:21]2[N:25]([CH2:47][C:48](OCC)=[O:49])[N:26]=[C:27]([C:28]3[CH:33]=[CH:32][C:31]([NH:34][S:35]([C:38]4[CH:43]=[CH:42][CH:41]=[C:40]([Cl:44])[C:39]=4[Cl:45])(=[O:37])=[O:36])=[C:30]([F:46])[CH:29]=3)[C:20]=12>COCCOC>[OH:10][C@@H:3]([C:4]1[CH:9]=[CH:8][CH:7]=[CH:6][CH:5]=1)[C@H:2]([N:11]([CH3:12])[C:48](=[O:49])[CH2:47][N:25]1[C:21]2=[N:22][CH:23]=[N:24][C:19]([NH2:18])=[C:20]2[C:27]([C:28]2[CH:33]=[CH:32][C:31]([NH:34][S:35]([C:38]3[CH:43]=[CH:42][CH:41]=[C:40]([Cl:44])[C:39]=3[Cl:45])(=[O:37])=[O:36])=[C:30]([F:46])[CH:29]=2)=[N:26]1)[CH3:1]
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

5

反応物 3

HCID 7028PseudoephedrineHCID 22346920Ethyl 2-[4-amino-3-(4-{[(2,3-dichlorophenyl)sulfonyl]amino}-3-fluorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]acetateHCID 178418339Butyllithium

生成物 1

HCID 69779418n1-[(1r,2s)-2-Hydroxy-1-methyl-2-phenylethyl]-n1-methyl-2-[4-amino-3-(4-{[(2,3-dichlorophenyl)sulfonyl]amino}-3-fluorophenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl]acetamide収率 20.3%

試薬・触媒・溶媒

1
HCID 80711,2-Dimethoxyethane溶媒

反応条件

温度
50 °C

実験手順

A solution of (+)-pseudoephedrine (0.037 g, 0.224 mmol) in ethylene glycol dimethyl ether (0.75 mL) was treated with a solution of n-butyllithium (2.5 M in hexanes, 0.060 mL, 0.150 mmol). After 20 min, this solution was transferred via cannula into a solution of ethyl 2-[4-amino-3-(4-{[(2,3-dichlorophenyl)sulfonyl]amino}-3-fluorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]acetate (0.040 g, 0.074 mmol) in N,N-dimethylfortnamide (0.75 mL). The resulting solution was stirred at 50° C. for 15 h. It was then cooled to ambient temperature and partitioned between methanol/dichloromethane (1:9, 50 mL), and water (15 mL). The organic layer was separated, dried over magnesium sulfate, filtered, and concentrated under reduced pressure. Purification by preparative HPLC (25 to 100% acetonitrile in 0.1 M aqueous ammonium acetate over 20 min at 21 mL/min using an 8μ Hypersil HS C18, 250×21 mm column, Rt 11.88-12.65 min) afforded N1-[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]-N1-methyl-2-[4-amino-3-(4-{[(2,3-dichlorophenyl)sulfonyl]amino}-3-fluorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]acetamide as an off-white solid (0.010 g, 0.015 mmol): RP-HPLC (25 to 100% acetonitrile in 0.1 M aqueous ammonium acetate over 10 min at 1 mL/min using a Hypersil HS C18, 250×4.6 mm column) Rt 9.63 min; MS: (MH)+ 658.

後処理

  1. temperatureIt was then cooled to ambient temperature
  2. custompartitioned between methanol/dichloromethane (1:9, 50 mL), and water (15 mL)
  3. customThe organic layer was separated
  4. dry with materialdried over magnesium sulfate
  5. filtrationfiltered
  6. concentrationconcentrated under reduced pressure
  7. customPurification by preparative HPLC (25 to 100% acetonitrile in 0.1 M aqueous ammonium acetate over 20 min at 21 mL/min

出典と根拠

ORDレコード
ord-da821c61fbc24811b72274798e2bd6bb
出典データセット
uspto-grants-2005_07
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US06921763B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート